Aviva Aesthetics Company Profile

Background

Overview

Aviva Aesthetics is a pioneering medical aesthetics platform founded in 2024 through a partnership between DuneGlass Capital and Pura Vida Med Spa & Cosmetic Laser Center. The company offers a unique Entrepreneur Equity™ model, enabling medical spa owners to retain full ownership and operational autonomy while benefiting from centralized support and resources. This approach provides an alternative to traditional private equity-backed platforms, allowing owners to preserve their businesses and clinical control.

Mission and Vision

Aviva Aesthetics aims to revolutionize the medical aesthetics industry by empowering entrepreneurs to maintain ownership and control over their practices. The company's mission is to provide med spa owners with the resources and support typically associated with private equity-backed platforms, without requiring them to sell their businesses or relinquish autonomy. This vision seeks to create a collaborative network of like-minded medical spa entrepreneurs dedicated to excellence in patient care and business growth.

Primary Area of Focus

The company focuses on the medical aesthetics industry, specifically targeting medical spa owners who wish to scale their businesses while maintaining ownership and operational control. Aviva Aesthetics provides a platform that combines the benefits of private equity with the advantages of entrepreneurship, offering a distinctive approach to growth and expansion in the med spa sector.

Industry Significance

Aviva Aesthetics addresses a significant gap in the medical aesthetics industry by offering an alternative to traditional private equity models. By enabling med spa owners to retain full ownership and control, the company fosters a more sustainable and owner-centric approach to growth and expansion. This model has the potential to reshape the industry by promoting collaboration, innovation, and long-term success for medical spa entrepreneurs.

Key Strategic Focus

Core Objectives

• Empowerment of Med Spa Owners: Provide a platform that allows med spa owners to retain full ownership and operational autonomy while accessing resources and support typically associated with private equity-backed platforms.

• Expansion and Growth: Build a collaborative network of high-performing medical spa practices across the United States, facilitating shared best practices and collective growth.

• Financial Optimization: Enhance the financial performance and valuation of partner practices, aiming for a 2-3x higher valuation compared to traditional private equity exits.

Specific Areas of Specialization

• Medical Aesthetics: Focus on advanced aesthetic treatments, including injectables, laser therapies, body contouring, and wellness services.

• Entrepreneurial Support: Offer resources and support to med spa owners to help them scale their businesses while maintaining ownership and control.

Key Technologies Utilized

• Centralized Support Systems: Implement centralized finance, accounting, HR, marketing, and procurement systems to streamline operations and reduce costs for partner practices.

• Data Analytics: Utilize data-driven tools to optimize business performance, enhance patient outcomes, and inform strategic decision-making.

Primary Markets Targeted

Aviva Aesthetics targets medical spa owners across the United States who are seeking growth opportunities without sacrificing ownership or autonomy. The company has expanded its footprint into various regions, including the Pacific Northwest, Midwest, Southeast, and South-Central markets.

Financials and Funding

Funding History

Aviva Aesthetics was founded in 2024 through a partnership with DuneGlass Capital, a healthcare services-focused independent sponsor. The company has not publicly disclosed specific funding amounts or details of subsequent funding rounds.

Total Funds Raised

Specific details regarding the total funds raised by Aviva Aesthetics are not publicly available.

Notable Investors

DuneGlass Capital, the founding partner, is a notable investor in Aviva Aesthetics. DuneGlass Capital specializes in forming doctor and entrepreneur-owned and led management services organizations (MSOs) in the healthcare sector.

Intended Utilization of Capital

While specific details on the utilization of capital are not publicly disclosed, it is likely that funds are allocated towards:

• Expansion Initiatives: Partnering with additional medical spa practices to expand the network.

• Operational Support: Enhancing centralized support systems for partner practices.

• Marketing and Growth Strategies: Developing and implementing marketing strategies to attract new clients and promote brand awareness.

Pipeline Development

Key Pipeline Candidates

Aviva Aesthetics has partnered with several leading medical spa practices, including:

• Illume Aesthetics: A top 2% Allergan practice and a top 5% medical spa offering injectables, located in Ashland, Oregon.

• Chrome Aesthetics: A premier medical spa in Albuquerque, New Mexico, known for advanced aesthetic and anti-aging treatments.

• Youthtopia Med Spa: A leading medical spa in Alpharetta, Georgia, recognized for advanced aesthetic treatments and a strong community presence.

• Aura Aesthetics: A top-rated medical spa in Portland, Oregon, offering customized, evidence-based aesthetic treatments.

• Luminate Clinic: A premier medical aesthetics and functional wellness practice in Tulsa, Oklahoma.

Stages of Clinical Trials or Product Development

As a platform supporting existing medical spa practices, Aviva Aesthetics does not engage in clinical trials or product development. Instead, it focuses on operational support, business growth, and resource optimization for its partner practices.

Target Conditions

The partner practices within Aviva Aesthetics offer a range of aesthetic treatments targeting various conditions, including:

• Skin Rejuvenation: Addressing signs of aging, sun damage, and skin texture issues.

• Body Contouring: Non-invasive procedures to reshape and contour the body.

• Injectables: Botox, dermal fillers, and other injectables for facial aesthetics.

• Wellness Therapies: Services such as hormone optimization and medical weight loss.

Relevant Timelines for Anticipated Milestones

Specific timelines for anticipated milestones are not publicly disclosed. However, the company continues to expand its network and support the growth of its partner practices.

Technological Platform and Innovation

Proprietary Technologies

Aviva Aesthetics utilizes proprietary support systems to enhance operational efficiency and business growth for its partner practices. These systems include centralized finance, accounting, HR, marketing, and procurement platforms.

Significant Scientific Methods

While Aviva Aesthetics does not engage in direct clinical treatments, its partner practices employ various scientific methods and technologies, including:

• Injectables: Botox, dermal fillers, and other injectables for facial aesthetics.

• Laser Treatments: Procedures for skin resurfacing, hair removal, and other applications.

• Body Contouring: Non-invasive procedures to reshape and contour the body.

• Wellness Therapies: Services such as hormone optimization and medical weight loss.

AI-Driven Capabilities

Specific details regarding AI-driven capabilities within Aviva Aesthetics are not publicly disclosed.

Leadership Team

Executive Profiles

• Tyler Weinberg – CEO

Tyler Weinberg serves as the Chief Executive Officer of Aviva Aesthetics. He is an entrepreneur and private equity veteran with extensive experience in the consumer and wellness industries. Tyler leads Aviva's strategic expansion and ensures the platform delivers comprehensive support to med spa owners.

• Dr. Leslie Apgar – Founding Doctor and Medical Director

Dr. Leslie Apgar is the founding doctor and medical director of Aviva Aesthetics. She is board-certified by the American Board of Obstetrics and Gynecology and is a Fellow of the American College of Obstetrics and Gynecology. Dr. Apgar is also the owner and medical director of Pura Vida Med Spa & Cosmetic Laser Center in Fulton, Maryland.

• Andrew Fatch – Chief Development Officer

Andrew Fatch serves as the Chief Development Officer of Aviva Aesthetics.